RxDoctor Payments Data

Mark Elder, DO

Family Medicine · Jay, FLNPI 1477559409

Payments from drug & device makers

$2,411in general payments, 2019–2025

Across 149 payments — averaging $16.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$617
  • AbbVie$403
  • Johnson & Johnson$312
  • Dexcom, Inc.$301
  • GSK$238
  • Novartis$115
  • plus $424 from 15 others

What the payments were for

  • Food & beverage$2,411100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,411 in reported general payments places this provider in the 75th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$18,695
Medicare patients
101
Services billed
294

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban248$124,599
OzempicSemaglutide60$77,561
FarxigaDapagliflozin Propanediol110$75,471
TrulicityDulaglutide58$57,300
LinzessLinaclotide77$45,745
RybelsusSemaglutide35$45,372
MounjaroTirzepatide38$42,003
Breztri AerosphereBudesonide/Glycopyr/Formoterol56$38,034
RexultiBrexpiprazole30$37,241
XareltoRivaroxaban90$33,663
JanuviaSitagliptin Phosphate37$29,040
Trelegy ElliptaFluticasone/Umeclidin/Vilanter24$25,120
Aimovig AutoinjectorErenumab-Aooe29$20,823
UbrelvyUbrogepant15$18,723
Potassium Chloride538$17,194

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus, Levemir$617$127,203118 claims
PfizerEliquis$75$124,599248 claims
AstraZenecaFarxiga, Breztri Aerosphere, Brilinta$26$121,212183 claims
AbbVieLinzess, Ubrelvy$403$64,46892 claims
Otsuka America Pharmaceutical, Inc.Rexulti$49$37,24130 claims
Johnson & JohnsonXarelto$312$33,66390 claims
GSKTrelegy Ellipta, Breo Ellipta$238$32,07741 claims
MerckJanuvia$23$29,04037 claims
Astellas Pharma US IncMyrbetriq$23$16,47831 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Jay

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →